The current future understanding of inflammatory bowel disease.
about
Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont SelectionTherapeutic approaches for celiac diseasePituitary adenylate cyclase-activating polypeptide ameliorates experimental acute ileitis and extra-intestinal sequelaeMatrix metalloproteinases in inflammatory bowel disease: an updateThe gut microbiota shapes intestinal immune responses during health and diseaseResveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitisSynergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells.Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosisGenetic and functional profiling of Crohn's disease: autophagy mechanism and susceptibility to infectious diseasesAssociation of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis.PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate.Nv-52: a novel thromboxane synthase inhibitor for the treatment of inflammatory bowel disease.β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway.Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice.Approaches for the identification of genetic modifiers of nutrient dependent phenotypes: examples from folate.Matriptase protects against experimental colitis and promotes intestinal barrier recoveryCritical roles of Notch and Wnt/β-catenin pathways in the regulation of hyperplasia and/or colitis in response to bacterial infectionRole of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice.CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibitionOral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.The role of TNFalpha in ulcerative colitis.Anti-inflammatory effects of novel AP-1 and NF-κB inhibitors in dextran-sulfate-sodium-induced colitis in rats.Autoimmunity against type VII collagen in inflammatory bowel diseaseAbnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats.Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis.Lung transplantation: infection, inflammation, and the microbiome.Insight into Crohn's disease pathomorphology.Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.Robust Microbiota-Based Diagnostics for Inflammatory Bowel Disease.Anti-inflammatory intestinal activity of Combretum duarteanum Cambess. in trinitrobenzene sulfonic acid colitis model.Regulation of colon cancer cell proliferation and migration by MD-2 activity.Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a(-/-) mice.Specific detection of OCT4 isoforms in inflammatory bowel disease.Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.Association of CARD8 with inflammatory bowel disease in Koreans.Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis.Production of IL-1beta, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis.A refined and translationally relevant model of chronic DSS colitis in BALB/c mice.
P2860
Q26774688-474C887D-FBDB-4AAD-841D-C7A80CEF6EA9Q26825413-5DC3711B-D136-4719-818E-CA6F05E30894Q27345033-7C42E270-C7C2-4269-B24C-74BBE73856BCQ28080664-AB0FEFA3-D637-49FC-AE8B-82F0AACDC3CCQ29547727-F7482C39-6C53-42E3-9C77-0AE307C0E28DQ33714931-D02E84A3-B96C-465E-A78E-30FC72D98475Q33772861-25D33285-3CE6-4436-BF52-0322E547A0A1Q33984006-439F908A-24FE-492F-8522-7819FC2CC00CQ34037058-9B6541B0-900D-4400-82CD-DC3347A75C0AQ34117874-D88CBE7F-8232-4947-8F19-6679B37EA29BQ34131110-D57EEA5C-6664-49C4-BE5E-C119D47A0110Q34654654-51CCA0FC-3A43-41C6-B583-4203786B2C3DQ34760736-32215C9F-0D1E-4E51-A626-E6B3580D408CQ35020376-AF56A261-D158-47A7-86D5-C1173C16A3D4Q35596531-0AC8B1F8-ED2A-44BB-9327-15A80B37116DQ35785774-CF9C624A-4FAA-43C2-9679-6C0917A3B4A9Q36163146-B67922D5-E69E-418C-9708-2E7DD921C48CQ36422338-66D47EDE-D883-4D16-8507-652408B0C438Q36732325-2C8F6ED3-1491-431B-952A-12AFB51C6000Q36755475-612FBB16-7351-4CB7-A824-6AC0D4D0119EQ36849148-50CDF618-245B-4C36-ADA4-D4A176257C3BQ36901080-1218CF2B-FC45-40C7-B4C8-9E1FD295B6B6Q37295360-B8F6C591-F99E-47D6-9B0C-3AC90FFAEA05Q37707732-C2F23AF0-9E9D-4912-8338-75A42CE01984Q37720153-6F3D86EA-B89D-45BA-AF2A-1E8BEAC77DEBQ37832677-7FF8AB05-9EC7-44D9-AD5E-FA3B3A13297DQ38000028-2CB551A6-3A23-4FEA-8D02-BB9CED3D4BC9Q38622923-B6FFD0FF-C3F0-40C8-A88D-A6AD2DED77BCQ38885391-3960C9A1-CBC2-42D9-9848-CC52C3CC83F6Q38908245-610E3AD0-4C71-4E09-90EA-C4875CA9B19AQ39668967-7BEE6CE9-12EB-4D20-8B60-EFDD8AE76A1CQ40521041-59671A93-9AD0-4EF6-8BAB-520E79987400Q40622345-F2B0B475-3EE4-4C3E-8CBC-1E0C14085156Q41465208-2EEF18F9-B13C-4CFB-AD3C-1AA18667C502Q42844822-F4E674D7-AC0C-4786-AFEA-8F9DFC9F8B72Q43850995-46B0AED6-7D78-4BC9-B428-026E3AECE1DFQ43886944-4A9F1CCD-6C9E-4B08-B580-2BD766D68055Q44690000-B5782745-BF24-4476-B144-302F6F64C872Q46610712-821B8C4D-1336-4EC3-B3F3-C22B81E9AD72Q47387828-0406FA3E-BCCB-443D-B861-E41EC1FD8437
P2860
The current future understanding of inflammatory bowel disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The current future understanding of inflammatory bowel disease.
@ast
The current future understanding of inflammatory bowel disease.
@en
type
label
The current future understanding of inflammatory bowel disease.
@ast
The current future understanding of inflammatory bowel disease.
@en
prefLabel
The current future understanding of inflammatory bowel disease.
@ast
The current future understanding of inflammatory bowel disease.
@en
P356
P1476
The current future understanding of inflammatory bowel disease.
@en
P2093
Daniel K Podolsky
P304
P356
10.1053/BEGA.2002.0354
P577
2002-12-01T00:00:00Z